Clinical Trial Update: NearWave Optical Molecular Monitoring [NA]

View source ↗

Summary

A recruiting clinical trial from Indiana University evaluating NearWave Optical Molecular Monitoring for breast cancer, including HER2-positive, HER2-negative, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Invasive Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Indiana University | Conditions: Breast Cancer, HER2-positive Breast Cancer | NA | Status: RECRUITING